Notably, sLNP‐OVA treatment significantly reduced lung neutrophil infiltration compared to PBS‐treated asthma mice (Figure 5F,G), while sLNP‐OVA/Cel treatment resulted in even less neutrophil infiltration compared to sLNP‐OVA‐treated mice (Figure 5F,G). This evidence concerns the gene CEL and asthma.